TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/3/24 21:30 | 7/1/24 | ALMS | Alumis Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tananbaum James B. | CA | DT | P.d | 40,000 | 16.00 | 0 | 2,500 | 87 | 5,379 | I | |||||||||||||||
5/10/23 17:49 | 5/8/23 | KNTE | Kinnate Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tananbaum James B. | CA | DT | P | 4,984 | 2.80 | 0 | 1,780 | 21 | 10,192 | I | |||||||||||||||
12/23/21 16:52 | 12/22/21 | PRDS | Pardes Biosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tananbaum James B. | CA | DT | P | 3,250 | 10.00 | 0 | 325 | New | 325 | I | |||||||||||||||
12/4/20 21:39 | 12/3/20 | KNTE | Kinnate Biopharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Tananbaum James B. | CA | DT | P | 20,000 | 20.00 | 0 | 1,000 | 125 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |